Mostrando 5 resultados de: 5
Filtros aplicados
Área temáticas
Enfermedades(4)
Farmacología y terapéutica(2)
Medicina y salud(2)
Economía(1)
Salud y seguridad personal(1)
Pharmacologic management of isolated low high-density lipoprotein syndrome
ArticleAbstract: High-density lipoprotein (HDL) cholesterol is a heterogeneous group of lipoproteins exhibiting a varPalabras claves:atherosclerosis, cholesterol, Coronary artery disease, dyslipidemia, HDLc, Reverse cholesterol transportAutores:Acosta L., Amell A., Arráiz N., Bermúdez F.A., Cano R.A., Cano-Ponce C., Finol F., Hernández-Hernandez R., Hidalgo J., Kendall P., Manuel V., Pabón M.R., Reyna-Villasmil N., Valmore BermúdezFuentes:scopusLipid profile reference intervals in individuals from Maracaibo, Venezuela: An insight from the Maracaibo City Metabolic Syndrome prevalence study
ArticleAbstract: Objectives: Cardiovascular diseases are the main cause of death in adults worldwide. Dyslipidemias aPalabras claves:Cardiovascular disease, dyslipidemia, lipid profile, Reference intervalsAutores:Aguirre M.A., Añez-Ramos R., Angulo V., Arráiz N., Bello L.M., Carem Prieto, Fortul Y., González M.C., Linares S., Marcano R.P., Naguib A., Pacheco E., Ponce C.C., Rojas-Quintero J., Salazar-Vílchez J., Silva C., Toledo A.C., Torres Y., Valmore Bermúdez, Villalobos M.Fuentes:googlescopusSerum lipoprotein (a) in patients post myocardial infarction
ArticleAbstract: Lipoprotein (a) [Lp (a)] is considered an independent risk factor for cardiovascular disease. In ourPalabras claves:Abdominal circumference, body mass index, dyslipidemia, Lipoprotein (a), myocardial infarctionAutores:Amell A., Añez-Ramos R., Arráiz N., Cano-Ponce C., Carem Prieto, Carrillo M., Cruz S., González M.C., Joselyn Zula, Montiel M., Salazar-Vílchez J., Silva C., Toledo A.C., Torres Y., Valmore Bermúdez, Vergara P.M.Fuentes:googlescopusPrimary dyslipidemias as risk factor for coronary heart disease
ReviewAbstract: Cardiovascular disease is the leading cause of death around the World. The Framingham's study was thPalabras claves:cholesterol, dyslipidemia, HDL-cholesterol, hypercholesterolemia, Hypertriglyceridemia, MutationsAutores:Arráiz N., Furgione A., Luti Y., Sánchez D., Scott G., Valmore Bermúdez, Velasco M.Fuentes:scopusThe maracaibo city metabolic syndrome prevalence study: Design and scope
ArticleAbstract: The metabolic syndrome (MS) is a conglomerate of interrelated risk factors-including obesity, atheroPalabras claves:Blood pressure, Cardiovascular Risk Factors, cross-sectional studies, dyslipidemia, Metabolic syndromeAutores:Amell A., Arráiz N., Cabrera M., Cano J.R., Cano R.A., Cano-Ponce C., Finol F., González J., Luti Y., Marcano R.P., Mengual-Moreno E., Miranda J.L., Montes J., Reyna-Villasmil N., Rojas E.R., Sánchez D., Sanchez W., Valmore Bermúdez, Vega L., Velasco M.Fuentes:scopus